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Abstract. Kinetic studies of prothrombin activation and intrinsic factor X activation car-
ried out in the absence and presence ofphospholipids and the protein cofactors Va or VIIIa
have provided insight in the mechanism by which the accessory components enhance coagu-
lation factor activation. In intrinsic factor X and prothrombin activation, phospholipids cause
a drastic drop of K- for the substrates factor X and prothrombin, whereas the protein cofac-
tors factor Va and factor VIIIa increase V-^* of the prothrombin- and factor X-activating
reactions. The mode of action of factor Va in prothrombin activation is however somewhat
more complex. Besides its stimulatory effect on the catalytic activity of factor Xa, Factor Va
also plays an important role in the assembly of the prothrombin-activating complex at phos-
pholipid surfaces especially when the latter have a low affrnity to1 vitamin-K-dependent
coagulation factors. This effect is likely accomplished by promoting the binding of both pro-
thrombin and factor Xa to the procoagulant surface.
Introduction
In the blood coagulation cascade, there are
several reactions which require the presence
of components, which by themselves have no
enzymatic activity but which greatly stimu-
late coagulation factor activation []. These
components, called nonenzymatic cofactors
or accessory components, are divided in pro-
tein cofactors and negatively charged proco-
agulant surfaces. Enzyme, substrate and pro-
tein cofactors bind to the negatively charged
surface and form an enzymatic complex that
is optimally active in substrate activation.
Thus, in the activation of the coagulation fac-
tors XII, XI and prekallikrein, enzyme-sub-
strate interaction is promoted by their bind-
ing to negatively charged surfaces like kaolin,
glass or sulfatides and by the protein cofactor
high-molecular-weight kininogen. For the ac-
tivation ofthe coagulation factors X and pro-
thrombin the protein cofactors are: factor
VIIIa for the intrinsic factor X activation, tis-
sue factor protein for the extrinsic factor X
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activation and factor Va for prothrombin ac-
tivation. The procoagulant surface, which
promotes prothrombin and also extrinsic and
intrinsic factor X activation, consists of
phospholipid bilayers that contain negatively
charged phospholipids. It is likely that under
physiological conditions activated blood
platelets provide the procoagulant surface
that promotes the assembly of the prothrom-
bin- and intrinsic factor-X-activating com-
plexes since upon stimulation with thrombin
plus collagen they expose negatively charged
phosphatidylserine in the outer monolayer of
their plasma membranes [2, 3].
The improvement of purification meth-
ods of the proteins involved in intrinsic fac-
tor X and prothrombin activation and the
development of chromogenic substrates pe-
cific for thrombin and factor Xa made it pos-
sible to obtain via a kinetic approach insight
in the role of the accessory components in
these reactions. In this paper we will summa-
rize kinetic studies carried out in our labora-
tory on prothrombin [4, 5] and intrinsic fac-
tor X activation [6]. The data obtained allow
a precise quantitation of the stimulatory ef-
fects of the accessory components and also
provide information about their mechanism
ofaction in coagulation factor activation.
Effect of the Nonenzymatic Cofactors on
the Kinetic Parameters of Prothrombin
and Factor X Activation
Prothrombin and intrinsic factor X acti-
vation are the most intensively studied vita-
min-K-dependent clotting factor activation
reactions. They have many features in com-
mon. Both the enzymes (factor Xa, factor
IXa) and the substrates (prothrombin and
factor X) are vitamin K-dependent proteins,
which contain y-carboxy glutamic acid resi-
dues that are important for the Ca2*-depen-
dent binding of these proteins to negatively
charged phospholipids. Both enzymes are
serine proteases. Also the protein cofactors
factor Va and factor VIIIa share several
properties. They have no enzymatic activity
of their own and both have to be activated by
thrombin to express their function in the
coagulation factor activation [7, 8]. Also fac-
tor V (Va) and factor VIII bind with a high
affinity to phospholipid bilayers [9, l0], al-
though they do not contain y-carboxyglu-
tamic acids.
The importance of the nonenzymatic co-
factors is illustrated in table I. We have sum-
marized the effects of the accessory compo-
nents on the rates of prothrombin and factor
X activation. It is clear that phospholipids
and the protein cofactor stimulate coagula-
tion factor activation in a multiplicative way.
Maximal rates of prothrombin and factor X
activation are obtained in the presence of
both phospholipids and the protein cofactor
(Va or VIIIa). In order to get more insight in
the mode of action of phospholipids, factor
Va and factor VIIIa in the prothrombin and
factor X activation, we have determined
their eflects on the kinetic parameters of co-
agulation factor activation [4, 6]. In the ab-
sence as well as in the presence of accessory
components, Lineweaver-Burk plots for pro-
thrombin and factor X activation were
straight lines from which the kinetic parame-
ters K- and V-u* could be determined. Ta-
ble II summarizes the effects of the accessory
components on the kinetic parameters for
prothrombin and intrinsic factor X activa-
tion. These data indicate that the role of fac-
tor Va and factor VIIIa in prothrombin and
factor X activation, respectively, is mainly
restricted to an effect on V.u*. Table II also
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Table I. Effect of nonenzymatic cofactors on relative rates of prothrombin and factor X activation
Prothrombin
activator a
Relative rate
of prothrombin
activation
Factor X
activator b
Relative rate
offactor X
actlvatlon
Xa
Xa, Ca2'
xa, Ca2,,PL
Xa, Ca2*, Va
xa, Ca2+, PL, va
I
2
5 X 1 0 2
2 . 3  X  1 0 3
'7.7 X 105
IXa
IXa, Ca2+
IXa, Ca2*, PL
IXa, Ca2+, VIIIa
IXA, CA2*, PL, VIIIA
I
8
2 . 3  X  1 0 3
5 . 3  X  1 0 6
PL = Phospholipid.
a I pM prothrombin, 5 mM CaClz 50 pM phospholipid (phosphatidylserine 25 0/0, phosphatidylcholine 75 o/0,
w/w) saturating factor Va.
b I pM faclor X, 5 mM CaClz, 50 pM phospholipid (phosphatidylserine 25 0/0, phosphatidylcholine 75 0/0, w/w)
saturating factor VIIIa.
reveals that the role of phospholipid in the
factor-X- and prothrombin-activating com-
plexes is restricted to an effect on K. for
factor X and prothrombin. In the absence
of phospholipid, the K- for prothrombin
(84pM and factor X (181 1ttr4) are consider-
ably higher than their plasma concentrations
(prothrombin 1.5 W, factor X 0.2 PM,
whereas upon addition of phospholipid to
both complexes, the K- drop to values well
below the plasma concentrations. This allows
both reactions to proceed at maximal veloc-
ity under physiological conditions, provided
that a negatively charged phospholipid sur-
face is present.
Mode of Action of Phospholipids in
Prothrombin and Factor X Activation
Table III shows that the enzymatic com-
plexes for factor X and prothrombin activa-
tion cannot be saturated by the addition of
increasing amounts of phospholipid. K. is
dependent on the phospholipid concentra-
tion such that K- for prothrombin and factor
X increase with increasing phospholipid con-
centrations. Thus, K. measured in the pres-
ence of phospholipid must be regarded as an
apparent Kn' (K."oo), which is a function of
the phospholipid concentration in the reac-
tion mixture.
In hgure l, three models are presented
which can explain the drop in Kn' after phos-
pholipid addition as well as the apparent
character of this kinetic parameter. The mod-
els are given for prothrombin activation in
the absence of factor Va and are presumably
also valid for intrinsic factor X activation in
the absence of factor VIIIa. Model I illus-
trates the situation in which a phospholipid-
bound factor Xa molecule has a conforma-
tional state (asterisk) different from the factor
Xa molecules in free solution. This confor-
mational change of phospholipid-bound fac-
tor Xa causes an increase of the affinity of
this molecule for prothrombin molecules
which are present in free solution. This in-
creased affinity between enzyme and sub-
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strate will result in a lowered K-"oo for pro-
thrombin.
Also in model 2, prothrombin molecules
originating from free solution interact di-
rectly with phospholipid-bound factor Xa
molecules, but in this model the bound factor
Xa molecules have not undergone a confor-
mational change. Binding of prothrombin to
phospholipid-bound factor Xa is promoted
by the additional affrnity of prothrombin to
negatively charged phospholipid molecules
in the direct environment of the factor Xa
molecule (dashed circle). Both in model 1
and model 2, the saturation of factor Xa is
directly dependent on the concentration of
prothrombin free in solution. When the
phospholipid concentration is increased,
more prothrombin is bound to phospholipid
leaving less prothrombin in solution avail-
able for interaction with phospholipid-bound
factor Xa. To obtain half maximal saturation
(i.e, K- conditions) of factor Xa with pro-
thrombin, more prothrombin must be added
at higher phospholipid concentrations. Since
K- for prothrombin is expressed in terms of
the concentration of total added prothrom-
bin, K-uoo will be higher at higher phospho-
lipid concentrations (cf. tabte ItI;.
In model 3, phospholipid-bound factor
Xa activates phospholipid-bound prothrom-
bin. In this model, half maximal satura-
tion of bound factor Xa is determined by
the local concentration of phospholipid-
bound prothrombin. The fact that the local
prothrombin concentration at the phospho-
lipid surface is higher than that in free solu-
tion explains the phospholipid-dependent
decrease of K- for prothrombin. However,
when the phospholipid concentration is
again increased, the bound prothrombin
molecules are diluted at the phospholipid
surface and more prothrombin must be
parameters of prothrombin andTable II. Kinetic
factor X activation
Prothrombin
actlvator
K* prothrom- V-"*, IIa.
bin, pM min-r 'Xa-l
Xa, Ca2+
Xa, Ca2*,PL
Xa, Ca2+ , PL, v a
0.68
2 .56
4,050
84
0 .  l l
0 . 1 4
Factor X activator K. factor X V-u*, Xa.
1 tM min- I ' IXa- r
lXa, Cazt
IXa, Ca2*, PL
IXa, Ca2*, PL. VIIIa
l 8 l
0 .36
0.29
0 .01
0.025
500
The kinetic parameters were measured at 50 1tM
phospholipid vesicles containing 25 molo/o phosphati-
dylserine and 75 mol0/o phosphatidylcholine.
PL = Phospholipid.
Table III. Effect of phospholipid on K- of pro-
thrombin for prothrombin activation and K- of factor
X for intrinsic factor X aclivation
Prothrombin activation Intrinsic factor X
actlvatlon
phospholipida
w
phospholipidb
w
Km"pp
w
rc-"0,
w
2 .6
I  0 .5
z o . 5
52.6
75
105
240
0.032
0.068
0. t64
0.25
0 .35
0.48
1.08
l 0
20
50
75
100
1 5 0
200
300
0.058
0 . 1  3 9
0.363
0.409
0 .525
0.822
1 . 8 3
t . 7  6
In these experiments, neither factor Va nor VIIIa
added.
a The phospholipid composition of the vesicles was
50 mol0/o phosphatidylserine and 50 mol0/o phosphati-
dylcholine.
b The phospholipid composition of the vesicles was
25 molo/o phosphatidylserine and 7 5 mol0/o phospha-
tidylcholine.
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Fig. l. Models for the mechanism of action of phospholipids in prothrombin (PT) activation in the absence
of factor Va. In all three models, phospholipid causes a decrease of the K-""" for prothrombin. For further
exolanations. see text.
added to restore the local concentration of
phospholipid-bound prothrombin required
for half saturation of phospholipid-bound
factor Xa. Thus, when K* is expressed in
terms of total prothrombin concentration,
also in model J, Kmann will increase at in-
creasing phospholipid concentrations. In
this model, it is expected, that, although
K.uoo increases with the phospholipid con-
centration, a K--expressed in terms of pro-
thrombin surface density would be con-
stant. Using binding parameters reported by
Nelsestuen and Broderirs [11] we calculated
prothrombin and factor X surface densities
at the K. presented in table IIL Figure 2
compares the measured Kmann for prothrom-
bin or factor X with the surface density of
bound prothrombin and factor X, at the Ko
concentrations. It is obvious that K' ex-
pressed in terms of surface density is inde-
pendent of the phospholipid concentration,
as might be expected in model 3.
In model I and model 2, the concentra-
tion of free substrate at K*uoo must be inde-
pendent of the phospholipid concentration.
Figure 2 shows that also the free prothrombin
and factor X concentration at K- are inde-
pendent of the phospholipid concentratlon.
Thus, on the basis of these calculations, we
cannot distinguish between the three pro-
posed models, since both the free substrate
concentration (requirement of model I and
2) and the surface density of substrate (re-
quirement of model 3) are independent of
and constant at diflerent phospholipid con-
centratrons.
Table IV shows the effect of variation of
the molar fraclion of phosphatidylserine in
phospholipid vesicles on the kinetic parame-
ters of prothrombin activation. In the ab-
sence of factor Va, vesicles containing 400/o
phosphatidylserine exhibit a 4O-fold lower
K-uoo than vesicles containing 2.50/o phos-
phatidylserine. Prothrombin aflinity for
phospholipid vesicles has been shown to in-
crease at increasing content of phosphatidyl-
serine in these vesicles [1 l]. Therefore, the
difference in K-uoo measured with phospho-
lipid vesicles containing varying molar per-
centages phosphatidylserine is likely caused
by differences of the afhninty of prothrombin
for these vesicles. In models 2 and 3, a lower
affinity of prothrombin for phospholipid re-
sults either in a lower affinity of the factor
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Fig.2. Effect of increasing the phospholipid concentration on K-"oo (o), Km expressed in terms of substrate
surface density (r) or K- expressed in terms of free substrate concentration (o). A Prothrombin activation
B Inlrinsic factor X activation.
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Table IV. Effect of phospholipid vesicles with dif-
ferent phosphatidylserine content on the kinetic pa-
rameters of prothrombin activation in the absence ol'
factor Va
Table V. E{Iect of phospholipid vesicles with dif-
ferent phosphatidylserine content on the kinetic pa-
rameters of prothrombin activation in the presence of
factor Va
Vesicle composition Kn
w
PS, O/O PC, O/O
V."t
I I a . m i n - 1 .
Xa- r
Vesicle composition Kn
w
V.u*
I I a . m i n - r '
Xa- lPS, O/O PC, o/o
40
30
20
1 0
5
2 .5
60
70
80
90
95
97.5
0 .  l 7
0 .20
0 .  l 9
0 .54
| . 6 6
3. ' t  1
J . J J
2.70
2.00
0 .83
0.33
0.08
40
30
20
l 0
5
2.5
60
't0
80
90
95
97.5
0.33
0.25
0 . 1  I
0.07
0.07
0 . 1 3
3,7 50
4,080
4 , t70
4,920
4,420
4 , t10
PS = Phosphatidylserine; pQ = phosphatidylcho-
l ine.
Kinetic parameters were determined at a phospho-
lipid concentration of 50 pM.
PS = Phosphatidylserine; pf = phosphatidylcho-
line.
Kinetic parameters were determined at a phospho-
lipid concentration of 50 FM.
Xa-phospholipid unit for prothrombin
(model 2) or in a decreased prothrombin den-
sity at the phospholipid surface (model 3),
which in both cases will result in an increase
of K-. In model 1, the charge of the phospho-
lipid surface is expected to be unimportant
for the conformational state of the phospho-
lipid-bound factor Xa, and moreover a de-
creased prothrombin binding to phospho-
lipid will result in an increase of the concen-
tration of prothrombin free in solution,
which will cause a further decrease of Km"ee.
We feel that on this basis and from the obser-
vation that acarboxyprothrombin, which has
a reduced amount of 1-carboxyglutamic
acids, gives in the presence of phospholipids
much lower reaction rates than prothrombin
[12], the conformational model (model l) is
Iess likely.
Also the V-u* of prothrombin activation
depends on the amount of phosphatidylser-
ine in the phospholipid vesicles. At lower
molar percentages of phosphatidylserine,
lower V-u* values are observed. This is likely
caused by the fact that these vesicles have a
lower affinity for factor Xa and thus bind less
factor Xa, which will decrease the amount of
factor Xa that participates in prothrombin
activation. This will result in the observation
of lower V-.* values.
The Role of Factor Va in Prothrombin
Activation
As we have seen in table II, the stimula-
tory effect of factor Va on prothrombin acti-
vation in the presence of phospholipid vesi-
cles with a high molar percentage of phospha-
tidylserine must be attributed to an increase
of Vmax [cf. a]. More recently it was observed
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Fig.3, Prothrombin activation
pathway. PT = Prothrombin; E =
prothrombin-activating complex;
PT2 = prothrombin 2; T = throm-
bin; Fl.2 = prothrombin fragment
1.2. Numbers 1-5 designate the
reaction steps explained in the text.
that factor Va also lowers K- for prothrom-
bin for membranes with a low affinity for
prothrombin [5, l3]. This effect of factor
Va on K- for prothrombin will be discussed
later.
The increase of the Vma* by factor Va is
the result of three additive effects: (1) a shift
in the reaction pathway of factor-Xa-cata-
lyzed prothrombin activation l4l, (2) an in-
crease of a forward rate constant in the pro-
thrombin activation pathway [4] and (3) an
increase of the amount of factor Xa that par-
ticipates in prothrombin activation [5, 16].
Figure 3 gives the minimal reaction mech-
anism for prothrombin activation that will be
helpful to explain the factor-Va-induced shift
in the prothrombin activation pathway. Gel-
electrophoretic analysis has shown that in the
absence of factor Va prethrombin 2 is the
main product of prothrombin activation [4].
This shows that the major reaction pathway
occurring under these conditions is that re-
presented by steps 1,2 and 5, and it also indi-
cates that prethrombin 2 easily dissociates
from factor Xa. In the presence of factor Va
there is almost no prethrombin 2 formation,
and thrombin is the major activation prod-
uct. Thus, factor Va changes the pathway of
prothrombin activation from one producing
prethrombin 2 (steps l, 2, 5) into one giving
rise to thrombin (steps 1-4). Apparently, the
presence of factor Va prevents the dissocia-
tion of prethrombin 2 from the prothrom-
binase complex, thereby increasing the rate
of thrombin formation.
Based on the estimation of the rate con-
stants of prethrombin 2 formation (without
factor Va) and thrombin formation (with fac-
tor Va), Tans et al. [7] concluded that apart
from the shift in the pathway factor Va must
also increase at least one forward rate con-
stant of the prothrombin activation pathway.
This was indeed shown to be the case by
Nesheim and Mann in 1983 [4]. From ki-
netic experiments with prothrombin and pro-
thrombin activation intermediates they con-
cluded that factor Va causes a 3,000-fold
increase of the k"u, of the factor-Xa-catalyzed
cleavage of the Arg323-Thr32a bond in pro-
thrombin (hg. 3 step 3).
The third effect of factor Va on V-u* of
prothrombin activation concerns its ability
to promote the binding of factor Xa to nega-
tively charged phospholipid vesibles [ 5, 16].
Especially for membranes with a low affinity
for factor Xa, this property of factor Va will
contribute to the increase of the V."*. This
phenomenon becomes clear upon compari-
son of the effects of procoagulant surfaces
with different phosphatidylserine content on
V-u* measured in the absence (table IV) or
presence of factor Va (table V). Without fac-
van Rijn/ZwaallHemker/Rostng
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tor va there rs a considerable decrease of accomplished by (1) a direct interaction 
of
v-"* at low molar percentages of phosphati- prothrombin with factor 
va' (2) a factor-va-
dylserine. This is likely ca-used by the fact induced clustering of 
negatively charged
that these membranes hu,,.. u low a{Iinity for phospholipid molecules around the 
enzy-
factor Xa [11] hence less factor Xa will par- matic unit that creates a better surface 
for
ticipate in prothrombin activation and lower prothrombin binding or 
(3) a factor-va-tn-
v_.* values will be observed. However, in iuced increase of a rate constant 
in the path-
the presence of factor Va there is hardly any
effect of ',ra.iation of the molar percentage of
phosphatidylserine on V-u* of prothrombin
activation (table V). This indicates that un-
der these conditions all added factor Xa par- proteases:
H'fii",'#"ffi"T"#,o;:;:::"#:tiT?lill- e+s5 u'+ s4 k" E* \
branes for factor Xa. This can be attributed in which
to the fact that factor Va has the ability to
promote the binding of factor Xa to the phos"- u.,, = ffi and K' 
= *' '[*j
pholipid vesicles' 
,rrpnrc nf facrnr va on r., tt is ,,,..rrunlr- it is possible rhat anApart from the effects of f tor V  
V . " * , t a b l e V a l s o s h o w s a n e f f e c t o f f a c t o r i n c r e a s e o f a s i n g l e r a t e c o n s t a n t ( k ; ) b r f a c -
V a o n K . f o r p r o t h r o m b i n w h e n p h o s p h o - t o r V a c a n c a u s e a n i n c r e a s e o f k . " . a n d a
lipid vesicles with a low molar percentage decrease of K-. At 
present u'e cannot give
phosphatidylserine are used as procoagulant preference to either of the three 
models stnce
surface. In the absence of factor va, low mo- p.op., kinetic data that 
would allo* discrim-
lar percentages of phosphatidylserine gave ination are not yet available'
high K- values. This could be easily ex-
ptaineO in models I and 2 (fig' 2), in which
lhe *eak affinity of prothrombin for the
phospholipid surface of vesicles containing Conctuding Remarks
low molar percentages of phosphatidylserine
The most important contribution of the
phospholipid surface in the actir ation of vi-
tamin-K-dependent coagulation factors ts to
promote the interactions betueen the pro-
in the vesicles. So apparently, factor va com- teins involved in these reactions' 
For this
pensates for the toss of binding affrnity of stimulatory effect, the proteins 
must har-e the
prothrombin for this kind of membrane sur- ability to bind to the procoagulant 
surface'
faces. several explanations are possible for The stimulation by surface 
is caused bl' the
the observation that factor va lowers K. of fact that the proteins have 
an affinitl' for the
pro thrombin forprocoagu lan tmembranesphospho l ip idsur faceandforeachother .a
with a low aflinity for vitamin-K-dependent combination which ensures 
effrcient protein-
coagulation factors. This phenomenon can be protein interactions at 
the surface' Thus'
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phopholipids stimulate prothrombin and fac-
tor X activation by facilitating enzyme-sub-
strate complex formation - a phenomenon
which is reflected in a large drop of K. of
their respective substrates.
The functions of the nonenzymatic pro-
tein cofactors, factors Va or VIIIa, are most
easily explained on the basis ofthe effects of
factor Va in prothrombin activation. It is
shown that factor Va acts in prothrombin
activation by enhancing the catalytic effi-
ciency of factor Xa, and by assembling factor
Xa and prothrombin to an enzymatic com-
plex at the phospholipid surface.
The marked effects of factor Va on the
kinetic parameters of prothrombin activa-
tion, which are found in the presence of phos-
pholipid vesicles with a weak affinity for fac-
tor Xa and prothrombin, are likely of physio-
logical importance. It is generally accepted
that in vivo stimulated blood platelets pro-
vide the procoagulant phospholipid surface
that serves the activation of prothrombin and
factor X since activated platelets expose
phosphatidylserine in the outer monolayer of
their plasma membrane. After activation
with physiological platelet activators (colla-
gen plus thrombin), the platelet outer mono-
layer contains, about 5 mol0/o phosphatidyl-
serine [1]. Such a membrane surface would
show weak interactions with prothrombin
and factor Xa in the absence of factor Va.
Therefore, factor Va will also play an impor-
tant role in the assembly of the prothrombin-
activating complex at the surface of blood
platelets. Since prothrombin and factor X
activation have many common features, it is
likely that phospholipids, factor VIIIa and
activated blood platelets act in a similar way
in intrinsic factor X activation as the corre-
sponding cofactors in prothrombin activa-
tron.
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